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Abstract
Biological and pharmaceutical samples represent formidable challenges in sample preparation that hold
important consequences for bioanalysis and genotoxic impurity quantification. This Feature will emphasize
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Sample Preparation for Bioanalytical and Pharmaceutical Analysis
Biological and pharmaceutical samples represent formidable challenges in sample preparation that
hold important consequences for bioanalysis and genotoxic impurity quantiﬁcation. This Feature will
emphasize signiﬁcant advances toward the development of rapid, sensitive, and selective sample
preparation methods.
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Department of Chemistry, Iowa State University, Ames, Iowa 50011, United States
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Art, LLC. Attributions for protein structures: Coﬁlin-1 (PDB ID 5HVK),
Galectin-1 (PDB ID 4Y1V), and Glyceraldehyde-3-Phosphate Dehydrogenase
(PDB ID 4Z0H).
A form of sample preparation prefaces virtually everyanalysis of a complex sample. Converting the sample into
a format that is compatible with analytical instrumentation may
be as straightforward as dilution or ﬁltration or may involve
multistep sample handling procedures. As one of the ﬁrst stages
in the analytical process, the selection of an appropriate sample
preparation technique is critical for obtaining reliable down-
stream measurements and consequently warrants careful
consideration.1 Many conventional methods entail signiﬁcant
user intervention, are time-consuming, and exhaust large
quantities of solvent and/or other consumables. Furthermore,
the demand for improved method sensitivity and selectivity has
begun to rapidly eclipse the capabilities of traditional sample
preparation techniques.2 This is particularly relevant for
complex sample matrixes where highly eﬃcient, more selective,
and low-cost extraction/puriﬁcation alternatives are becoming
increasingly desirable.
Biological samples represent formidable sample preparation
and analysis challenges due to the presence of interfering
constituents within the sample matrix. Contaminants in these
complex samples may clog sampling and extraction devices,
nonspeciﬁcally interact with analytes, coextract with target
compounds, and/or foul instrumentation through adsorp-
tion.3,4 Adding to the diﬃculty, the sample matrix often
contains only trace levels of analyte that require a form of
preconcentration or puriﬁcation in order to deliver a suﬃcient
quantity of target compound to the analytical instrument.5
This Feature article will highlight a selection of sample
preparation challenges that have signiﬁcant impact in the life
sciences and pharmaceutical industry. Important advances in
these areas will be emphasized and can often be attributed to a
fundamental understanding of the physicochemical properties
of the analyte and sample matrix.
■ SAMPLE PREPARATION FOR NUCLEIC ACID
ANALYSIS
Within biological systems, nucleic acids (NAs) are responsible
for the storage and transfer of genetic information that is
essential for organism function and development. Apart from
their critical role in natural processes, the analysis of NAs has
become indispensable for a multitude of scientiﬁc and medical
disciplines including genomics, clinical diagnostics, food safety,
and forensic analysis. Modern sequencing and detection
techniques are capable of rapidly generating enormous amounts
of information from high-quality NA. However, puriﬁcation of
DNA or RNA is often marked by laborious, time-consuming
procedures and represents a signiﬁcant bottleneck in the
analytical workﬂow.
Since NA constituents represent an exceedingly small
quantity of total cellular material, the isolation and preconcen-
tration of NAs are requisite steps for most applications.
Sensitive ampliﬁcation techniques, such as polymerase chain
reaction (PCR), are frequently employed to facilitate the
detection of trace amounts of NA. However, enzyme-based
ampliﬁcation methods require the input of highly pure samples.
Interferences that diminish ampliﬁcation eﬃciency or inhibit
PCR altogether may originate from the cell itself (e.g., proteins)
or the surrounding environment (e.g., humic acids in soil) and
must be removed prior to analysis. While the identity and
abundance of interfering agents within a given sample often
dictate the sample preparation method, NA extraction
Published: October 25, 2016
Feature
pubs.acs.org/ac
© 2016 American Chemical Society 11262 DOI: 10.1021/acs.analchem.6b02935
Anal. Chem. 2016, 88, 11262−11270
techniques generally possess common objectives that include
cell lysis, separation of NAs from the bulk sample matrix, and
reconstitution in a medium compatible with downstream
experiments. Several examples of NA extraction methods are
displayed in Table 1.
■ LIQUID PHASE NUCLEIC ACID EXTRACTION AND
PURIFICATION TECHNIQUES
One of the earliest and most commonly used techniques for
NA isolation relies on a liquid−liquid extraction (LLE) method
involving a mixture of phenol and chloroform. In this classical
approach, cells are lysed using detergents, chaotropes, or heat in
order to release NAs into solution. Denatured proteins, lipids,
and other cellular components are extracted into the phenol-
chloroform layer while NAs remain in the aqueous phase. By
controlling the pH of the system, the method may be applied
for the selective isolation of DNA or RNA. Subsequent
precipitation of the NAs is accomplished using ethanol or
isopropanol, followed by reconstitution in a medium suitable
for downstream analysis. Modiﬁcation of cell lysis conditions/
solvent composition has led the LLE technique to be widely
adopted for NA isolation from tissues,6 plant material,7 and
sediments.8
While phenol-chloroform extraction has been used for the
puriﬁcation of NAs from a variety of complex samples, the
method is not without limitations. The multiple sample
preparation steps required for this method are time-consuming,
laborious, and severely reduce sample throughput. Further-
more, the large volumes of toxic organic solvent consumed in
this approach have raised health and environmental concerns,
leading many researchers to seek alternative solvent-based
extraction methods. One approach to minimizing the use of
organic solvent is to develop miniaturized NA extraction
methods within microﬂuidic devices. Microﬂuidic systems are
comprised of microchannels and chambers ﬁxed in a chip
through which small volumes of sample, solvent, and reagents
are manipulated. Morales and co-workers designed a micro-
ﬂuidic device for the puriﬁcation of NAs using a liquid
extraction technique based on the diﬀerential partitioning of
DNA and protein between an aqueous phase and an organic
phase consisting of phenol, chloroform, and isoamyl alcohol.9
To enhance the partitioning of protein to the organic phase,
droplet-based ﬂow was employed to maximize the interfacial
area between the aqueous and organic phases. The microﬂuidic
platform was applied for the puriﬁcation of plasmid DNA
(pDNA) from bacterial cell lysate with subsequent quantiﬁca-
tion by gel electrophoresis. In addition to minimizing the use of
organic solvents, droplet-based DNA puriﬁcation within
microﬂuidic devices circumvents the need for manual sample
handling procedures.10,11 Zhang et al. later demonstrated the
isolation and ampliﬁcation of NAs from bacterial cell lysate with
a microﬂuidic liquid phase puriﬁcation system.12 In their
approach, as shown in Figure 1, bacterial cell lysate was loaded
into the microwells of the NA puriﬁcation chip and a mixture of
phenol, chloroform, and isoamyl alcohol was cycled back and
forth over the wells to ensure partitioning of proteins to the
organic phase. The organic phase was ﬂushed to waste and
residual organic solvent evaporated from the microwells by
applying a vacuum, followed by washing of the dried NA with
70% ethanol. DNA and RNA extracted using this approach
were suﬃciently pure to serve as templates for on-chip real-time
quantitative PCR (qPCR) and reverse transcription qPCR
(RT-qPCR) analysis, respectively.
In some cases, organic solvent can be eliminated from NA
sample preparation methods altogether. Enzyme-based meth-
ods have recently been described that enable rapid cell lysis and
degradation of protein contaminants to liberate DNA for
downstream analysis. The method relies on a proteinase from
the thermophilic Bacillus sp. Erebus antarctica 1 (EA1) that
extensively hydrolyzes cellular proteins, including nucleases,
Table 1. Examples of Nucleic Acid Extraction Methods from Biological Samples







Phenol-chloroform DNA or RNA/tissue, plant, sediment PCR yes yes 6−8
EA1 enzyme-based DNA/buccal swab On-chip PCR not required not required 16
Silica beads B. anthracis DNA/whole blood On-chip PCR not required yes 34
Polymeric ionic liquid pDNA/bacterial cell lysate qPCR not required not required 36, 38
Magnetic oligo(dT) beads mRNA/3T3 cell lysate RT-qPCR not required not required 43
Magnetic ionic liquid pDNA/bacterial cell lysate PCR not required not required 46, 47
Figure 1. Schematic of RNA puriﬁcation using a microﬂuidic liquid
phase extraction technique. Panels a−c show removal of protein and
DNA from aqueous RNA within microwells. Drying and wash steps
are depicted in panels d−f, enabling RT-qPCR as shown in panels g
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when incubated at 75 °C.13 Upon centrifugation of the
resulting suspension to remove cell debris, DNA in the
supernatant is suitable for PCR ampliﬁcation. Since the
enzyme-mediated extraction of DNA occurs within a closed
sample tube, this technique is particularly useful for forensic
analysis where minimizing the risk of sample contamination
with exogenous DNA is of paramount importance. Lounsbury
and co-workers investigated the extraction and PCR
ampliﬁcation of DNA from forensic samples, such as whole
bloodstains and buccal swabs using the EA1 enzyme DNA
extraction method.14 The authors subsequently adapted the
enzyme-based method to a poly(methyl methacrylate)
(PMMA) microdevice and noted that the sample incubation
time could be dramatically reduced (from 20 min to
approximately 60 s) while still generating PCR-ampliﬁable
DNA. The enzyme-based DNA method has also been
employed in microdevices that integrate sample preparation,
DNA ampliﬁcation, and detection in single-use microﬂuidic
chips.15,16
Recent eﬀorts in the development of liquid phase NA
extraction techniques not only seek to minimize organic solvent
consumption and analysis time but also enhance the selectivity
of the extraction media for NAs. Ionic liquids (ILs) constitute a
growing class of solvents comprised of readily customizable
organic cations and organic/inorganic anions with melting
points at or below 100 °C. An attractive feature of ILs is the
ability to synthetically install functional groups in the cation or
anion component that facilitate speciﬁc interactions between
the IL solvent and analytes. Wang and co-workers found that
the 1-butyl-3-methylimidazolium hexaﬂuorophosphate
([BMIM+][PF6
−]) IL was capable of extracting up to 99% of
double-stranded DNA from aqueous solution using a LLE
technique.17 Using 31P NMR to observe changes in the
chemical shift of the DNA phosphate backbone, electrostatic
interactions between the [BMIM+][PF6
−] IL and DNA were
determined to be the driving force for DNA extraction. Further
investigation of a variety of IL extraction solvents revealed that,
in addition to electrostatic interactions, hydrogen bonding and
hydrophobic interactions also played a role in the enhanced
DNA extraction eﬃciencies.18
Buﬀer systems comprised of IL additives have proven useful
for the extraction of genomic DNA from challenging sample
matrixes including maize19 and processed meats.20 By stirring
the biomass within a buﬀered solution of imidazolium or
choline-based ILs at elevated temperature, NAs were released
into solution and isolated by the sedimentation of cellular
debris. Although DNA yields were reportedly lower than
conventional extraction methods (e.g., surfactant-assisted
extraction), the IL-based extraction provided DNA of suﬃcient
purity for qPCR with a shorter overall sample preparation time.
■ SOLID PHASE EXTRACTION OF NUCLEIC ACIDS
Solid phase extraction (SPE) is a widely used sample
preparation technique in analytical chemistry and has become
increasingly popular for the isolation of NAs. A typical SPE
procedure for NA puriﬁcation involves cell lysis, binding of
NAs to the sorbent material, a wash step to remove interfering
agents, and elution of the NA in an appropriate buﬀer for
downstream analysis. Numerous SPE sorbents have been
reported for NA extraction including anion exchange resins,21
alumina membranes,22 and chitosan-modiﬁed particles.23
However, silica-based substrates constitute the most widely
applied materials for solid phase NA puriﬁcation. Under
chaotropic conditions, DNA adsorbs to silica in a process
thought to be facilitated by dehydration of DNA and the silica
surface, hydrogen bonding interactions, and shielding of the
negatively charged moieties on DNA and silica.24 Lowering the
solution pH results in superior DNA adsorption, likely due to
neutralization of the weakly acidic silanol groups on the silica
surface.25 The adsorption of RNA to silica is also observed
using similar conditions.26 Importantly, the chaotrope-driven
binding of NA to silica is reversible, where elution of DNA or
RNA can be achieved using low ionic strength aqueous buﬀers.
Commercially available silica-based chemistries for NA
puriﬁcation exist in a variety of formats with spin columns
and ﬁlters among the most common. After cell lysis and
centrifugation of cellular debris, the aqueous supernatant rich in
NAs is passed over the silica sorptive phase in the presence of a
chaotrope using centrifugation or an applied vacuum. In many
cases, enzymes such as proteinase K are added to the cell lysate
to degrade proteins prior to the NA binding step. The sample
may also be treated with ribonucleases (RNases) in order to
enzymatically degrade RNA when selective isolation of DNA is
desired. Although similar in SPE sorbent composition,
comparison of DNA extraction performance for a number of
silica spin columns from diﬀerent manufacturers reveal a wide
range of DNA yields and purities that are often sample matrix
dependent.27,28 Nonetheless, commercially available silica-
based SPE methods have been successfully applied for NA
isolation from complex matrixes including soil, food, and blood
samples, with the capacity for semi or fully automated
workﬂows.29 However, automation of these centrifuge or
vacuum-based macroscale SPE techniques requires sophisti-
cated equipment that is cost-prohibitive to most users.
The translation of SPE technologies to microscale platforms
represents an important advancement toward the development
of inexpensive diagnostic systems that can readily function for
rapid, on-site testing applications.30 Some key advantages of
miniaturizing NA sample preparation methods include reduced
manual sample handling, decreased assay volumes, and shorter
analysis times.31 Initial eﬀorts to incorporate silica-based
extraction phases within microﬂuidic channels involved the
fabrication of silica micropillars possessing high surface area for
DNA capture.32 In this approach, an aqueous DNA solution
was ﬂowed through the device in the presence of a chaotrope to
bind NA to the micropillars. Following an ethanol wash, DNA
could then be eluted using a Tris-EDTA buﬀer. A similar bind,
wash, and elute protocol was followed to extract HindIII
digested λ-phage DNA from aqueous solution using a
microdevice loaded with silica beads.33 Oﬀ-line PCR
ampliﬁcation experiments demonstrated suﬃcient purity of
the NA extracted by the microdevice. A fully integrated
microﬂuidic system was later developed by Easley and co-
workers that incorporated the necessary on-chip processes for
genetic analysis of whole blood samples.34 Since the reagents
used for silica-based DNA extraction act as PCR inhibitors (e.g.,
chaotropes and alcohols), the authors carefully isolated the SPE
and PCR portions of the device.
In contrast to relatively mature silica-based DNA extraction
methodologies, polymeric ionic liquid (PIL) substrates have
recently been explored as tunable DNA extraction sorbents.
Wang and co-workers prepared PIL microspheres using an
imidazolium-based IL monomer and a N,N′-methylene bis-
(acrylamide) cross-linker for the extraction of pDNA from
bacterial cell lysate.35 The DNA binding capacity of the PIL
microspheres was nearly 200 μg mg−1 with 80% of the DNA
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recovered when a sodium chloride desorption solution was
employed. PILs have also been applied as sorbent coatings for
the extraction of DNA using solid phase microextraction
(SPME).36 SPME, which was developed by Pawliszyn and co-
workers in 1990,37 is a technique in which analytes are
extracted by exposing a thin ﬁber coated with a layer of sorbent
to a sample solution. This technique combines sampling and
sample preparation into a single step, which can signiﬁcantly
increase sample throughput while also decreasing the cost of
the analysis due to the reusability of the SPME device. Using a
PIL-based SPME device consisting of an imidazolium-based
monomer and dicationic IL cross-linker, DNA was extracted
from crude bacterial cell lysate and analyzed by qPCR.38 In this
approach, DNA extraction was found to proceed through an
ion-exchange mechanism in which the negatively charged
phosphate groups in DNA exchanged with the halide anions of
the PIL sorbent coating. The SPME platform showed
considerable promise for high-throughput NA analysis while
circumventing the need for organic solvents and centrifugation.
■ MAGNET-BASED SAMPLE PREPARATION FOR
NUCLEIC ACIDS
Many LLE and SPE NA puriﬁcation methods revolve around
tedious, manual sample handling procedures and lengthy
centrifugation steps that result in limited sample throughput.
These challenges are unsustainable for high-throughput
laboratories where NA analysis plays an essential role. The
development of magnetoactive extraction media has provided a
platform that is ideally suited to address the shortcomings of
traditional NA sample preparation techniques. Magnet-based
approaches utilize a magnetic extraction phase for the rapid
enrichment and manipulation of NAs. In a process that
bypasses centrifugation, extracted NAs can be easily isolated
from the bulk sample matrix by the simple application of a
magnetic ﬁeld.
Magnetic beads and particles for DNA/RNA separations
often consist of a magnetic core (e.g., iron oxide) encapsulated
by various functional coatings that are capable of reversibly
binding NAs.39 When employed for the extraction of DNA
from cell lysates, homogenized tissues, and other complex
biological samples, the DNA-enriched sorbent can be magneti-
cally controlled and separated from cellular debris and solid
interferences. Using well-established silica-based binding
chemistry, commercially available silica-coated paramagnetic
particles extract DNA under chaotropic conditions.40 Leslie and
co-workers developed a method for DNA sample preparation
and quantiﬁcation using magnetic silica beads.41 In this
approach, human blood samples were lysed using guanidine
hydrochloride and subsequently mixed with magnetic silica
beads within a PMMA microwell. When a rotating magnetic
ﬁeld was applied, adsorption of human genomic DNA to the
silica surface resulted in aggregation of the magnetic beads. The
bead aggregation formed the basis for an optical detection and
quantiﬁcation method where a greater degree of aggregation
indicated higher DNA concentration. As shown in Figure 2,
release of the DNA from the magnetic beads with a low ionic
strength buﬀer reversed the aggregation and yielded PCR-
ampliﬁable template.
Functionalization of magnetic beads with single-stranded
oligonucleotides represents a useful approach for the sequence
speciﬁc enrichment of NAs. By selectively extracting a particular
NA sequence, background signals produced by untargeted
molecules in sensitive bioanalytical assays can be minimized.
These magnetic substrates are uniquely suited for the capture of
polyadenylated mRNA via hybridization when appended with a
polythymine nucleotide sequence (oligo(dT)). After cell lysis
and target sequence hybridization, noncomplementary NA
sequences can be removed by a washing step. Magnet-based
sequence speciﬁc extraction has been leveraged for rapid
mRNA extraction from blood,42 single cell mRNA capture,43
and mutation analysis.44
Very recently, magnetic ionic liquid (MIL) solvents were
examined as DNA extraction media. MILs are a subclass of ILs
that possess similar tunable physicochemical properties while
also exhibiting susceptibility to magnetic ﬁelds.45 Using a
similar approach to that displayed in Figure 3, highly eﬃcient
extractions of salmon testes DNA from aqueous solution
(∼90% eﬃciency) were observed using microvolumes of
tetrahaloferrate(III)-based MILs.46 Furthermore, MILs were
applied for the extraction of pDNA from crude bacterial cell
lysate in a magnet-based method that was directly interfaced
with PCR ampliﬁcation.47 The MIL-based approach was
capable of yielding PCR-ampliﬁable pDNA without organic
solvents or centrifugation in a process that required less than 2
min of sample preparation. When coupled with the DNA
preservation capabilities of these magnetic solvents,48 a
workﬂow involving DNA extraction, storage, and subsequent
analysis can be accomplished using PCR-compatible MILs.
Figure 2. Extraction of DNA from whole blood using magnetic silica
bead aggregation. DNA is released from the beads using Tris-EDTA,
ampliﬁed using PCR, and the PCR products separated using
electrophoresis. (Adapted with permission from ref 41. Copyright
2012 American Chemical Society).
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■ EXTRACTION AND PURIFICATION OF
METABOLITES AND BIOMARKERS FROM
BIOLOGICAL SAMPLES
Metabolomics is a ﬁeld of research concerned with the
comprehensive analysis of low molecular weight metabolites
in biological systems. The analysis of such compounds promises
to oﬀer deeper insight into the mechanisms of disease and
provide important biomarkers for diagnostic applications.
Moreover, a greater understanding of the lifestyle and dietary
factors that contribute to speciﬁc diseases can be gleaned from
metabolic signatures.49 One major challenge in metabolomics is
the lack of approaches that are capable of identifying, detecting,
and quantifying a broad range of metabolites that may span
several orders of magnitude in their respective concentrations.
Analytical instrumentation and/or hyphenated techniques
including gas chromatography or liquid chromatography
combined with mass spectrometry (GC−MS or LC−MS),
nuclear magnetic resonance spectroscopy (NMR), and capillary
electrophoresis (CE) are frequently employed in an attempt to
fully characterize the metabolites within a given biological
sample.49 Although direct instrumental analysis minimizes the
loss of analytes, interfering agents within the sample matrix
(e.g., salt and macromolecules) can signiﬁcantly aﬀect the
sensitivity and reproducibility of the analytical method. For
example, excess salt content in the sample matrix may result in
adduct formation and/or ion suppression during MS
analysis.49,50 In GC applications, the accumulation of non-
volatile interferences in the inlet and at the head of the GC
column can lead to active site formation, analyte degradation,
and result in retention time shift and poor quantitation. To
solve these issues, an appropriate sample preparation method
must be judiciously selected and employed prior to
instrumental analysis, particularly when confronted with
complex biological samples.
Protein precipitation is widely used in the processing of
biological samples to concentrate proteins and purify them
from various contaminants. It is also considered to be one of
the fastest and simplest approaches for the removal of protein
interferences from biological samples (e.g., serum and plasma).
In practice, acetonitrile or methanol is injected into the sample
to precipitate protein constituents followed by a centrifugation
step to sediment the insoluble protein. This approach has been
widely adopted for metabolomics proﬁling of plasma,51 analysis
of illicit drugs and their metabolites in oral ﬂuid52 and detection
of vitamin D metabolites in plasma.53 To further increase the
throughput of the experiment, a fully automated protein
precipitation procedure was developed by Watt et al. in which a
96-well plate and a robotic liquid handling system was
employed for the sample preparation and analysis of more
than 400 plasma samples per day.54 Despite the advantages
stated above, the sample may still contain a signiﬁcant amount
of soluble protein interferences due to the poor selectivity of
this approach.55 Moreover, coprecipitation of the analytes of
interest can also diminish the recovery of the method.
Classical LLE is the most popular method for the extraction
of metabolites from biological samples. When choosing the
extraction solvent, a number of things need to be considered
including toxicity, solubility, selectivity, chemical reactivity, and
pH. Perchloric acid is one of the most suitable solvents for the
extraction of polar, hydrophilic or basic compounds, such as
primary metabolites. To ensure the reproducibility of
metabolite analysis, quenching must be applied immediately
after sample collection to prevent metabolite degradation or
decomposition that can alter the original metabolite proﬁle of
the organism. One advantage of using perchloric acid as an
extraction solvent is that it immediately quenches enzymatic
reactions and denatures proteins, yielding a protein free
extraction. However, this approach requires pH adjustment
for each sample prior to NMR analysis to avoid peak shifts in
the spectra.56 Furthermore, the presence of perchlorate salts
can make the method incompatible with chromatographic
separations. For the extraction of moderately polar and
nonpolar metabolites, organic solvents such as methanol or
ethanol are often employed. Binary mixtures of solvents (e.g.,
mixture of methanol and water/acidiﬁed water) typically
provide superior results when the extraction of a broader
range of metabolites is desired.57
Although conventional LLE methods have been widely
adopted for the isolation and preconcentration of metabolites
in biological samples, a number of shortcomings still remain.
LLE consumes relatively large volumes of organic solvents with
expensive disposal requirements. During the LLE process,
emulsions may form that prevent adequate phase separation
and, consequently, lead to diﬃculties in quantitative recovery of
the extracted analytes. Moreover, LLE often requires time-
consuming and laborious sample handling procedures that are
not readily automated without the use of expensive and
sophisticated equipment. Advances in liquid phase extraction
seek to address these issues with liquid−liquid microextraction
(LLME) techniques, including single-drop microextraction
(SDME), hollow ﬁber liquid phase microextraction (HF-
LPME), and dispersive liquid−liquid microextraction
(DLLME). When coupled to state-of-the-art analytical
instrumentation, these methods often provide faster analysis
times, higher sample throughput, lower solvent consumption,
Figure 3. Depiction of MIL-based extraction. (A) 20 μL droplet of
MIL in 2 mL of aqueous DNA solution. (B) Dispersion of MIL into
ﬁne droplets using agitation. (C and D) Retrieval of DNA-enriched
MIL droplets using a 0.66 T rod magnet. (Adapted with permission
from ref 45. Copyright 2016 Elsevier).
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and even higher sensitivity. Though not the focus of this
Feature, recent developments in LLME techniques for
bioanalytical applications have been reviewed.55,58 Because of
their user-friendliness and cost-saving potential, it is expected
that these techniques will continue to play an important role in
the future of metabolite analysis.
SPE is a well-established method for sample cleanup and
preconcentration of semivolatile/nonvolatile metabolites in
biological samples at trace levels. This technique has many
advantages including high recovery, eﬀective preconcentration,
and lower organic solvent consumption (compared to LLE)
and is generally easy to automate.55 Furthermore, SPE devices
(e.g., columns, cartridges) may also function as a ﬁlter
preventing suspended solids from contaminating or clogging
instrumentation. This is particularly relevant for complex
biological sample matrixes for which a ﬁltration step following
protein precipitation is usually required.59 In practice, the
sample is introduced into the SPE device and analytes of
interest partition between a solid extraction phase and a liquid
phase. The SPE sorbent can be chosen to strongly retain
interfering matrix components and thus remove them from the
sample or to selectively retain analytes while matrix
components pass through to waste. The latter approach is
most commonly applied since analytes can then be
preconcentrated by using small volumes of eluent. In order
to select the appropriate SPE sorbent for the method, it is
important to consider the physical and chemical properties of
the target analytes and the sample matrix. Common SPE
sorbents include chemically bonded silica with various
functional groups (e.g., C8 and C18), carbon or ion-exchange
materials, polymeric materials (e.g., cross-linked styrene-
divinylbenzene), immunosorbents, molecularly imprinted poly-
mers, restricted access materials, and monolithic sorbents.60
SPE methods have also been conﬁgured for online sample
preparation prior to an analytical separation in order to increase
sample throughput and minimize tedious sample handling
procedures.61
While useful in many cases, SPE suﬀers from disadvantages
including time-consuming method development, the potential
for irreversible analyte adsorption, and higher cost since as SPE
cartridges are often designed for single use. Moreover, SPE
typically requires organic solvents for elution and the poor
batch-to-batch reproducibility with respect to the sorbent
material can also be of concern.55 To address these challenges,
SPME has been employed as a rapid and cost-eﬀective method
for the extraction of metabolites with a broad range of
properties. Analytes that are preconcentrated using SPME are
rapidly desorbed using a high temperature GC inlet or HPLC-
compatible organic solvent for GC or HLPC analysis,
respectively. For the analysis of metabolites in biological
samples, the choice of the SPME sorbent coating depends on
the purpose of the study. Adsorptive coatings like divinylben-
zene/Carboxen/polydimethylsiloxane (DVB/CAR/PDMS) are
widely applied for metabolomics ﬁngerprinting and proﬁling
studies since they are capable of extracting compounds
comprising a broad range of volatilities and polarities.62
When a more targeted analysis is desired, selective coatings
such as polyacryl (PA) and Carbowax may be more appropriate
choices.
SPME can be performed using two diﬀerent extraction
modes, namely, headspace and direct immersion. In the
headspace extraction mode, the SPME ﬁber is exposed to the
headspace above the sample matrix (e.g., fruit, plant, human
tissue, and urine). This sampling approach avoids direct contact
of the ﬁber with the sample and therefore minimizes the risk of
contaminating the extraction phase. However, this method is
only suitable for extracting highly volatile metabolites since
nonvolatile or low volatility compounds are not readily
transferred to the headspace.62 In direct immersion SPME,
the ﬁber is immersed in the sample whereby analytes partition
between the sample matrix and the sorbent coating. This
extraction mode can improve the capture of high molecular
weight and polar metabolites. However, the adsorption of
macromolecules on the surface of the ﬁber represents a
potential drawback of direct immersion SPME and may result
in fouling of the ﬁber and poor reproducibility. In one approach
reported by Mirnaghi and co-workers, a biocompatible C18-
polyacrylonitrile sorbent was applied for an automated 96-blade
SPME system (see Figures 4A and B). The sorbent coating
exhibited good extraction recovery, long-term reusability, and
good reproducibility for the extraction of diazepam, lorazepam,
oxazepam, and nordiazepam from human plasma samples.63
Another form of direct immersion SPME has recently emerged
in which biocompatible sorbent coatings are applied for
sampling and extraction of metabolites in vivo. This method
combines extraction and metabolism quenching in a single step,
which can signiﬁcantly prevent the oxidation or enzymatic
degradation of metabolites after removal from their natural
biological milieu.64 A schematic of in vivo SPME for global
metabolomics studies of blood/plasma is shown in Figure 4C.
When coupled with LC−MS, hundreds of metabolites could be
extracted with high sensitivity and precision comparable to
traditional methods (i.e., ultraﬁltration, plasma protein
precipitation). Moreover, in vivo sampling allowed detection
of short-lived metabolites including β-NAD, AMP, and
glutathione, which could not be detected by other methods.65
To date, in vivo SPME has been successfully applied to various
biological systems including microorganisms, plants, animals,
insects, and human emissions.66
Figure 4. (A) Concept 96-blade SPME device coated with C18-
polyacrylonitrile; (B) schematic demonstration of autosampler for 96-
blade SPME device. (C) In vivo SPME sampling of mouse blood.
(Adapted with permission from refs 63 (Copyright 2011 American
Chemical Society) and 65 (Copyright 2011 Wiley)).
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Stir bar sorptive extraction (SBSE) is another versatile
sample preparation technique that involves the extraction and
enrichment of metabolites from biological samples. This
technique is based on the principle of sorptive extraction,
where solutes are extracted by a polymer coating (e.g., PDMS)
on a magnetic stirring rod. After extraction, the solutes can be
desorbed using heat or a suitable solvent for GC or LC analysis.
In comparison to SPME, a larger volume of extraction phase is
used in SBSE, which can result in higher sensitivities for trace
level analysis.67 PDMS is the most widely used extraction phase
for SBSE due to its broad temperature range and high stability
toward various organic solvents. However, the limited solvation
properties provided by PDMS render SBSE unsuitable for the
extraction of polar compounds. Since metabolites within
biological samples often possess high polarity, in situ
derivatization prior to extraction has been used to yield higher
sensitivity and improved chromatographic behavior.68
■ SAMPLE PREPARATION FOR GENOTOXIC
IMPURITIES IN PHARMACEUTICAL ENTITIES
Trace level genotoxic impurities (GTIs) in pharmaceuticals are
of increasing concern to both the pharmaceutical industry and
regulatory agencies. The major source of GTIs is usually active
pharmaceutical ingredient (API) manufacturing, which involves
the use of genotoxic reagents, organic solvents, and catalysts.69
GTIs are compounds that can possess unwanted toxicities,
including genotoxicity and carcinogenicity. Stringent regula-
tions were developed by the United States Food and Drug
Administration (FDA) and the European Medicines Agency
(EMA) to control the amount of GTIs tolerable in
pharmaceutical entities.70,71 Depending on the dose and
duration of exposure, allowable daily intake values can be as
low as 1.5 μg/person/day, which is equivalent to low parts-per-
million (ppm) or sub-ppm concentration ranges of GTIs in
drug substances. Thus, monitoring the presence of various
GTIs in drug substances is of great importance for the
pharmaceutical industry and consumer health.
Direct injection of pharmaceutical samples to HPLC or GC
is the most common approach for the determination and
quantiﬁcation of GTIs. Other approaches including chemical
derivatization, matrix deactivation, and coordination ion spray
MS have been reported to further enhance sensitivity.72
However, since most APIs present in pharmaceutical samples
exhibit low volatility, direct injection of the sample for GC
analysis can result in contamination of the GC inlet and the
head of the GC column. Moreover, in order to determine GTIs
at low ppm levels, an extremely large quantity of API sample is
usually required for direct injection analysis. This can result in
serious band broadening of the main components (i.e., APIs)
during chromatographic separation, increasing the complexity
of the separation and peak integration. To address these issues,
headspace GC (HS-GC) has been reported for the analysis of
volatile GTIs.73 This approach minimizes the amount of
nonvolatile matrix components introduced to the GC by
sampling only the gaseous components in a heated sample vial.
Recently, ILs were used as a new class of diluents for the
analysis of GTIs in small molecule drug substances by HS-GC.
The low volatility and high thermal stability of ILs enables the
method to be used at high HS-GC oven temperatures with
minimal chromatographic background when compared to
conventional HS-GC diluents such as dimethyl sulfoxide and
dimethylacetamide. As a result, a signiﬁcant improvement in the
sensitivity for high boiling GTIs was achieved.74
Another approach for the analysis of GTIs involves API
removal from the sample by extraction and puriﬁcation
methods, with LLE being the most common. Organic solvents
such as methyl tert-butyl ether and n-hexane exhibited high
selectivity for alkylating agents including dimethyl sulfate, alkyl
mesylates, and alkyl besylates.75,76 Yang and co-workers
demonstrated that ethylmethanesulfonate (EMS) could be
generated from the APIs in the GC inlet at high temperature
via transesteriﬁcation reaction, resulting in a considerable
overestimation of EMS in APIs (see Figure 5A).77 To solve this
problem, the API sample was dissolved in an appropriate
solvent (i.e., dichloromethane) followed by the addition of an
antisolvent (i.e., n-hexane) to precipitate the matrix substance.
EMS was extracted into the mixture of dichloromethane and n-
hexane with little residual API and subsequently injected for
GC−MS analysis. As shown in Figure 5B, interferences were
removed following this sample pretreatment approach and the
false positive for EMS was eliminated.
SPE has also been exploited as a preconcentration technique
for the analysis of GTIs in APIs. An online HPLC-SPE-HPLC
method was demonstrated by Yamamoto and co-workers for
the selective determination of synthetic intermediates in APIs.78
In this approach, the eluent from the ﬁrst column was
introduced via heart-cutting to a SPE column. Subsequently,
analytes that retained on the SPE column were transferred to a
second column for further separation. A linear range from 0.25
to 250 ppm was obtained.
SPME is also a powerful technique for the preconcentration
of GTIs in drug substances. The PDMS/DVB and Carboxen/
PDMS sorbent coatings were successfully applied for the
Figure 5. (A) GC−MS chromatograms of standard and API samples
obtained using the direct injection method (operated at diﬀerent inlet
temperatures). (B) GC−MS chromatograms of a standard, spike
recovery sample, and sample after precipitation. (Adapted with
permission from ref 77. Copyright 2015 Elsevier).
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extraction/determination of GTIs (i.e., methyl and ethyl ester
derivatives of select sulfonic acids, aziridine, and 2-chloroethyl-
amine) in APIs.79,80 Recently, the application of PILs as SPME
sorbent coatings resulted in the parts-per-billion and parts-per-
trillion ultratrace level quantiﬁcation of GTIs and structurally
alerting compounds (i.e., alkyl halides and aromatics).81
Since GTIs cannot be entirely eliminated from API
production, puriﬁcation must be performed until the
concentrations of GTIs in APIs are lowered to acceptable
levels. Conventional puriﬁcation techniques include recrystal-
lization, preparative HPLC, precipitation, and distillation.
However, some of these methods are time-consuming and
can result in low yields of API, which in turn increases the cost
of the ﬁnal product. Recently, selective API puriﬁcation
platforms including reactive scavengers,82 organic solvent
nanoﬁltration (OSN),83 and molecularly imprinted poly-
mers84,85 have been developed. In one approach reported by
Esteves and co-workers, a molecularly imprinted polymer in
combination with OSN was employed for the successful
removal of 99.7% of GTIs from the API while incurring a loss
of just 8% API.85 These emerging sample preparation methods
will foreseeably provide valuable alternatives to conventional
techniques in the future of rapid and selective GTI analysis.
■ CONCLUSIONS AND OUTLOOK
Sample preparation is a key component of successful chemical
analysis. Extraction, puriﬁcation, and preconcentration techni-
ques are particularly relevant for the quantiﬁcation of trace
analytes in complex sample matrixes. Some of the most
demanding samples are derived from natural biological systems
and consequently require innovative sample preparation
methods to achieve selective or comprehensive analysis. The
practical implementation of new sample preparation technol-
ogies will also be determined by sample throughput require-
ments, where the facilitation of laboratory automation can be
expected to have substantial impact. Moreover, the continual
development of highly eﬃcient and selective extraction media is
critical for meeting the necessary method detection limits
enacted by regulatory agencies. The environmental outcomes of
sample preparation must also continue to be considered. A
number of advances have been made toward the miniatur-
ization of extraction and puriﬁcation systems that enable the
handling of smaller sample and solvent volumes. These formats
include microdevices, microextraction sorbents, and micro-
extraction techniques that will likely continue to provide
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